LVAD/Stem Cell Combination Therapy in Nonischemic Dilated Cardiomyopathy Patients: Proof-of-Concept Study

Purpose: Cell therapy was associated with reverse remodelling and improved outcome in patients with nonischemic dilated cardiomyopathy (NICM). We are performing a study to evaluate the safety and feasibility of this approach in NICM patients undergoing long-term LVAD support.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , G. Poglajen, S. Frljak, G. Zemljic, A. Cerar, I. Knezevic, R. Radovancevic, U. Jorde, I. Gregoric Source Type: research